Saxondale

Private Investor - just my opinions not investing advice . Small Mcap Pharma and Gold Mining . Small companies - good management - big dreams #FARN #GGP #AVCT

[Saxondale @Saxondale14]

@LLSusa @OncNewsCentral Any mention of how well the drug Bexmarilimab is doing in the fight against r/r MDS in the BEXMAB trial . The next big TAP success story ?

[Saxondale @Saxondale14]

I wonder if one of the leading companies making progress in Immunotherapy treatments will be involved in this ? Huge breakthrough happening in this field at the moment with #FARN https://t.co/GUejhC1lrv

[Saxondale @Saxondale14]

We are just starting to get a feel of what value to put on the @FaronPharm Bexmarilimab platform . The Bexmab partner deal will be the first of many over the next few years unless an offer comes in that they can't refuse . #solidtumoursnext #Bexcombo

[Saxondale @Saxondale14]

@BMHLTD and don't forget that Christine Roth ( Bayers head of Oncology strategic business unit ) sits on BOD at Faron pharma . Bayer are a prime partner candidate or even potential buyer .

[Saxondale @Saxondale14]

@BMHLTD @FaronPharm @JuhoJalkanen They see the FDA news warranting positive SP action , and will come back with a revised valuation after H1 results . Th Bull case at present still only 5 euro - well out of date IMO - I expect a lot more .

[Saxondale @Saxondale14]

@BMHLTD @FaronPharm @JuhoJalkanen Here's one from Aug 23 . SP was 3.41 euro Mcap 221 euro . Fair value seen at 12 euro bull case , given the known data from Bexmab which was limited - and no FDA guidance . https://t.co/QF5goSNFgR

[Saxondale @Saxondale14]

@BMHLTD @FaronPharm

[Saxondale @Saxondale14]

@BMHLTD @FaronPharm Add to that the huge support they have had from the Leukemia & Lymphoma Society getting Bexmab to the premium clinics , and having a track record of helping bring new drugs to market . It is 100% nailed on since the FDA news . Only decision now is to partner up or accept a bid .

[Saxondale @Saxondale14]

I think todays news at Faron Pharmaceuticals will fire the starting pistol for what will be a game changing second half of the year for the company . So much more to Bex than just the MDS trial . Looking forward to more details next week. Well done again ! #FARN #BEX #LLS

[Saxondale @Saxondale14]

Things are hotting up at @FaronPharm . Well done to all the crew . The countdown to liftoff begins.... #Bex #Farn #Partner

[EuropeanPatentOffice @EPOorg]

What if our immune system could better fight cancer cells?

🇫🇮 inventors Sirpa and Markku Jalkanen are redefining what's possible at @FaronPharm with a breakthrough in immune technology.

Show your support & vote: https://t.co/AN0m5kaWEW

@InFLAMES_Health
#InventorAward #MedTech

[Saxondale @Saxondale14]

All those connected with @FaronPharm must be very proud today . Almost a lifetimes work in order to finally make such a huge difference for future generations . The future looks brighter because of these two . #Bex https://t.co/76xuD9CKjc

[Saxondale @Saxondale14]

@FaronPharm Big thanks to Markku for all his work over these last years . It hasn't been an easy ride - but he has assembled a top notch team to take Bex forward . And welcome Juho to the new role . " One ring to rule them all " ! Good luck - exciting times ahead 🇫🇮🇬🇧🇺🇸🚀👍

[Saxondale @Saxondale14]

“The drug has by now been tested on 250 patients. It would appear to be safe and actually be able to limit the spread of cancer. This is the greatest possible reward for a person who has worked on the research for the whole of their career.” #Bexmarilimab #Clever1 #FARN

[Sigrid Jusélius Stiftelse @SigridJuselius]

Long-term teamwork by Sirpa Jalkanen’s research group is set to culminate in the best possible result, a new drug limiting the spread of cancer.

Read the article: https://t.co/spMYPhhRPe

#WorldCancerDay
@SinaTadayonn @InFLAMES_Health

[Saxondale @Saxondale14]

One of Immumotherapies being trialed is Bexmarilimab in combination with azacitidine - Bexmab trial is showing highly encouraging results . Looking forward to P2 data #AML #azacitidine #bex #FARN

[Targeted Oncology @TargetedOnc]

WATCH: Naval G. Daver, MD, discusses the unmet needs that still exist in the treatment of #AML. #leusm | @Daver_Leukemia @MDAndersonNews

https://t.co/lba1H3CCtq

[Saxondale @Saxondale14]

Word is spreading ... Bexmarilimab research features in the Januarys edition of Cancer Immunology Research magazine ! #Bexmarilimab #FARN #FARON #MDS #AML #LLS

[Cancer Immunology Research @CIR_AACR]

Read the new priority brief—
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments, by Jenna H. Rannikko et al.
https://t.co/78xJwhHzXQ
@MedicityL

[Saxondale @Saxondale14]

This slide illustrates how the Bexmarilimab treatment platform is at last going to be put into real world use . First up - higher risk MDS patients. Possibly within months ! Come on FDA - lets get this done . #Bex #FARN #MDanderson #LLS #MDS #BEXMAB